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Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning
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Inserm 1095, 3) EHESP French School of Public Health, Aix Marseille Université, IRD French Institute of Research for Development, Marseille, France, 4) WHO
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Abstract
A cohort of 154 French Hajj pilgrims participating in the 2012 Hajj were systematically sampled with nasal swabs prior to returning to
France, and screened for the novel HCoV-EMC coronavirus by two real-time RT-PCR assays. Despite a high rate of respiratory symptoms
(83.4%), including 41.0% influenza-like illness, no case of HCoV-EMC infection was detected. Despite the fact that zoonotic transmission
was suspected in the first few cases, a recent family cluster in the Kingdom of Saudi Arabia suggests that the virus might show at least limited
spread from person to person, which justifies continuing epidemiological surveillance.
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Abstract
The human immunodeficiency virus (HIV) mutational archive of proviral DNA was monitored during a 72-week follow-up in 20
multidrug-experienced HIV-1-infected patients treated with a darunavir/ritonavir-based salvage therapy. At the beginning of the study, all
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases
ONLINE-ONLY RESEARCH NOTES VIROLOGY
patients harboured a number of intracellular drug resistance-associated mutations (RAMs) in peripheral blood mononuclear cells. In some
patients, a significant fluctuation in the number of RAMs was observed during the observation period. However, all patients, notwithstanding
the presence or the fluctuation of intracellular RAMs, showed a persistently undetectable viraemia. The data suggest that the archived
resistant viral variants change during suppressive therapy, but that the variants are unable to re-emerge and to affect virological response.
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